Literature DB >> 35481937

Assessing health status after discharge for decompensated heart failure: a patient-centred priority.

Nosheen Reza1, Javed Butler2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35481937      PMCID: PMC9299400          DOI: 10.1002/ejhf.2521

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   17.349


× No keyword cloud information.
  15 in total

1.  Health-Related Quality of Life Outcomes in PARADIGM-HF.

Authors:  Eldrin F Lewis; Brian L Claggett; John J V McMurray; Milton Packer; Martin P Lefkowitz; Jean L Rouleau; Jiankang Liu; Victor C Shi; Michael R Zile; Akshay S Desai; Scott D Solomon; Karl Swedberg
Journal:  Circ Heart Fail       Date:  2017-08       Impact factor: 8.790

Review 2.  Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review.

Authors:  John A Spertus; Philip G Jones; Alexander T Sandhu; Suzanne V Arnold
Journal:  J Am Coll Cardiol       Date:  2020-11-17       Impact factor: 24.094

3.  Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).

Authors:  Candace D McNaughton; Alex McConnachie; John G Cleland; John A Spertus; Christiane E Angermann; Patrycja Duklas; Jasper Tromp; Carolyn S P Lam; Gerasimos Filippatos; Ulf Dahlstrom; Kenneth Dickstein; Anja Schweizer; Sergio V Perrone; Mahmoud Hassanein; Georg Ertl; Achim Obergfell; Mathieu Ghadanfar; Sean P Collins
Journal:  Eur J Heart Fail       Date:  2022-05-12       Impact factor: 17.349

Review 4.  2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Authors:  Paul A Heidenreich; Biykem Bozkurt; David Aguilar; Larry A Allen; Joni J Byun; Monica M Colvin; Anita Deswal; Mark H Drazner; Shannon M Dunlay; Linda R Evers; James C Fang; Savitri E Fedson; Gregg C Fonarow; Salim S Hayek; Adrian F Hernandez; Prateeti Khazanie; Michelle M Kittleson; Christopher S Lee; Mark S Link; Carmelo A Milano; Lorraine C Nnacheta; Alexander T Sandhu; Lynne Warner Stevenson; Orly Vardeny; Amanda R Vest; Clyde W Yancy
Journal:  Circulation       Date:  2022-04-01       Impact factor: 39.918

5.  Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.

Authors:  Jasper Tromp; Sahiddah Bamadhaj; John G F Cleland; Christiane E Angermann; Ulf Dahlstrom; Wouter Ouwerkerk; Wan Ting Tay; Kenneth Dickstein; Georg Ertl; Mahmoud Hassanein; Sergio V Perrone; Mathieu Ghadanfar; Anja Schweizer; Achim Obergfell; Carolyn S P Lam; Gerasimos Filippatos; Sean P Collins
Journal:  Lancet Glob Health       Date:  2020-03       Impact factor: 26.763

6.  The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.

Authors:  Mikhail N Kosiborod; James L Januzzi; John A Spertus; Mary C Birmingham; Michael Nassif; C V Damaraju; Antonio Abbate; Javed Butler; David E Lanfear; Ildiko Lingvay
Journal:  Nat Med       Date:  2022-02-28       Impact factor: 87.241

7.  Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.

Authors:  Javed Butler; Stefan D Anker; Gerasimos Filippatos; Muhammad Shahzeb Khan; João Pedro Ferreira; Stuart J Pocock; Nadia Giannetti; James L Januzzi; Ileana L Piña; Carolyn S P Lam; Piotr Ponikowski; Naveed Sattar; Subodh Verma; Martina Brueckmann; Waheed Jamal; Ola Vedin; Barbara Peil; Cordula Zeller; Faiez Zannad; Milton Packer
Journal:  Eur Heart J       Date:  2021-03-31       Impact factor: 29.983

8.  Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.

Authors:  Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; Martina Brueckmann; Michael Böhm; Vijay K Chopra; João Pedro Ferreira; James L Januzzi; Sanjay Kaul; Ileana L Piña; Piotr Ponikowski; Sanjiv J Shah; Michele Senni; Ola Vedin; Subodh Verma; Barbara Peil; Stuart J Pocock; Faiez Zannad; Milton Packer; Stefan D Anker
Journal:  Circulation       Date:  2021-11-15       Impact factor: 39.918

9.  Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.

Authors:  Mikhail N Kosiborod; Christiane E Angermann; Sean P Collins; John R Teerlink; Piotr Ponikowski; Jan Biegus; Josep Comin-Colet; João Pedro Ferreira; Robert J Mentz; Michael E Nassif; Mitchell A Psotka; Jasper Tromp; Martina Brueckmann; Jonathan P Blatchford; Afshin Salsali; Adriaan A Voors
Journal:  Circulation       Date:  2022-04-04       Impact factor: 39.918

10.  The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.

Authors:  Ewa A Jankowska; Bridget-Anne Kirwan; Mikhail Kosiborod; Javed Butler; Stefan D Anker; Theresa McDonagh; Maria Dorobantu; Jarosław Drozdz; Gerasimos Filippatos; Andre Keren; Irakli Khintibidze; Hans Kragten; Felipe A Martinez; Marco Metra; Davor Milicic; José C Nicolau; Marcus Ohlsson; Alexander Parkhomenko; Domingo A Pascual-Figal; Frank Ruschitzka; David Sim; Hadi Skouri; Peter van der Meer; Basil S Lewis; Josep Comin-Colet; Stephan von Haehling; Alain Cohen-Solal; Nicolas Danchin; Wolfram Doehner; Henry J Dargie; Michael Motro; Tim Friede; Vincent Fabien; Fabio Dorigotti; Stuart Pocock; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2021-06-03       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.